Mingye Feng MD, PhD

Dr. Mingye Feng is an Associate Professor at the Beckman Research Institute, City of Hope Comprehensive Cancer Center. His research focuses on macrophage-based cancer immunotherapy, including elucidating the mechanisms of macrophages-tumor cell interaction and identifying immune evasion tactics employed by tumor cells to escape macrophage surveillance. Building on these insights, Dr. Feng and his team are developing therapeutic strategies that harness the tumoricidal capabilities of macrophages, including antibodies, small molecule compounds, and engineered macrophages. His work has received support from funding agencies such as NIH, the V Foundation for Cancer Research, and the Damon Runyon Cancer Research Foundation.